Metadon Dak

Methadone Hydrochloride, the active ingredient in Metadon Dak, is a opioid analgesic presented as a tablet for oral use. It treats opioid dependence and provides analgesia for moderate to severe pain in appropriate patients.

GNH USA supplies Metadon Dak as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methadone Hydrochloride is used in the management of opioid‑related conditions and pain syndromes.

- Opioid dependence: helps suppress withdrawal symptoms and supports long‑term abstinence. - Moderate to severe pain: provides effective analgesia for chronic or acute pain when other treatments are insufficient. - Opioid use disorder: stabilises patients during maintenance therapy and reduces illicit opioid use.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: occasional upset stomach or vomiting. - Constipation: reduced bowel movements, often requiring dietary adjustments. - Drowsiness: increased sleepiness or fatigue. - Sweating: excessive perspiration, especially at night. - Dry mouth: reduced salivation leading to discomfort. - Dizziness: feeling light‑headed or unsteady.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - QT interval prolongation: cardiac rhythm disturbance that may cause arrhythmia. - Seizures: rare episodes of convulsive activity. - Severe hypotension: marked drop in blood pressure. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing or dispensing Methadone Hydrochloride, several safety considerations are essential.

- Assess tolerance: confirm patient’s opioid tolerance before initiating therapy. - Monitor respiration: observe breathing rate, especially during dose adjustments. - Cardiac evaluation: check baseline ECG for QT prolongation risk. - Hepatic function: adjust dosing in patients with liver impairment. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone Hydrochloride can interact with a variety of medicines, influencing its safety and efficacy.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, alcohol): may cause profound respiratory depression. - MAO inhibitors: increase risk of serotonin syndrome and hypertensive crisis. - QT‑prolonging drugs (e.g., antiarrhythmics, certain antibiotics): heighten arrhythmia risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise methadone plasma levels.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce methadone effectiveness. - Other opioids: additive sedation and respiratory effects. - Certain antidepressants (e.g., SSRIs, SNRIs): may alter methadone metabolism. - Antihistamines: can increase drowsiness and dizziness.